IntraFuse, a start-up incubated by Surgical Frontiers, received U.S. Patent No. 10,136,929, “Flexible Bone Implant” for its FlexThread™ Intramedullary Fracture Fixation System.
The patent covers the novel combination of an intramedullary rod with cross fixation on one end and a flexible bone screw on the other end. This platform technology enables percutaneous, secure fracture fixation of long bones of the extremities, especially for curved bones or where the surgical technique requires an off-axis approach to the intramedullary canal.
This is IntraFuse’s first patent issued from its intellectual property portfolio, which includes additional pending global patent applications.
The FlexThread system is FDA 510(k)-cleared for fibula and clavicle indications and is in development for use in fractures of the fifth metatarsal bone.
Source: Surgical Frontiers
IntraFuse, a start-up incubated by Surgical Frontiers, received U.S. Patent No. 10,136,929, “Flexible Bone Implant” for its FlexThread™ Intramedullary Fracture Fixation System.
The patent covers the novel combination of an intramedullary rod with cross fixation on one end and a flexible bone screw on the other end. This platform technology...
IntraFuse, a start-up incubated by Surgical Frontiers, received U.S. Patent No. 10,136,929, “Flexible Bone Implant” for its FlexThread™ Intramedullary Fracture Fixation System.
The patent covers the novel combination of an intramedullary rod with cross fixation on one end and a flexible bone screw on the other end. This platform technology enables percutaneous, secure fracture fixation of long bones of the extremities, especially for curved bones or where the surgical technique requires an off-axis approach to the intramedullary canal.
This is IntraFuse’s first patent issued from its intellectual property portfolio, which includes additional pending global patent applications.
The FlexThread system is FDA 510(k)-cleared for fibula and clavicle indications and is in development for use in fractures of the fifth metatarsal bone.
Source: Surgical Frontiers
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
